Clinical Trials

Mitochondrial DNA Neurobiology Pediatrics Pharmaceuticals Adverse Effects Computing Weight Loss Strategies Brain-Computer Interfaces Brain Function Age-related Diseases

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

The phase 1 data reveal sustained weight reduction with tolerable gastrointestinal effects ahead of planned 2026 phase 3 trials.

Experimental Diabetes Pill Burns Fat Without Muscle Loss, Advances to Phase II Trial

Meta-Analysis Shows Rapamycin Matches Dietary Restriction in Extending Vertebrate Lifespans

CAR T-Cell Therapy Yields Lasting Remission in Chronic Inflammatory Demyelinating Polyneuropathy

UCSF Researchers Target Variant Bladder Cancer With CAR-T Therapy

Silencing Enzyme Gene Boosts NK Cell Cancer-Fighting Power

Brain Implant Enables Real-Time Speech for Man With ALS

Colorado’s CURBy Beacon Publishes Daily Verifiable Quantum Random Numbers

Inherited Mitochondrial Variant Linked to Checkpoint Inhibitor Resistance in Metastatic Melanoma

Personalized Home Exercise and Coaching Enhance Fitness in Neuromuscular Disorders

Stanford’s Milli-Spinner Clot-Densifying Device Nears Human Trials

Anti-CD30 therapy restores PD-1 immunotherapy efficacy in resistant skin cancers

Experimental ALS Drug Shows Unprecedented Effects in Rare Genetic Cases

AI Blood Test ARTEMIS-DELFI Revolutionizes Pancreatic Cancer Treatment Monitoring

Baylor Researchers Identify Flavonoids That Target Bladder Cancer Cells

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies

UCSF Research Advances Prenatal Therapy for Spinal Muscular Atrophy

STAT3 Degraders Poised for Clinical Trials to Combat Immunotherapy Resistance

SYNT-101 Shows Promise in Early Human Trials as a Non-Invasive Obesity Treatment

New BTC Cell Line Atlas Unveils Molecular Subtypes and Therapeutic Targets